Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide- but not from ethylene oxide- induced DNA strand breaks

Environmental and Molecular Mutagenesis

Volumn 30, Issue 4, 1997, Pages 429-439

  Herrero, María Elena ^a   Arand, Michael ^a   Hengstler, Jan Georg ^a   Oesch, Franz ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Alkaline elution; Carcinogen; Metabolism; Xenobiotic

Indexed keywords

EPOXIDE HYDROLASE; ETHYLENE OXIDE;

ANIMAL CELL; ARTICLE; CHO CELL; DNA STRAND; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME LOCALIZATION; NONHUMAN;

ANIMALS; CELL LINE; CRICETINAE; CRICETULUS; DNA DAMAGE; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; ETHYLENE OXIDE; HUMANS; LUNG; MICROSCOPY, FLUORESCENCE; MICROSOMES;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031416480     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1997)30:4<429::AID-EM8>3.0.CO;2-D     Document Type: Article

References (65)

1. Alvares AP (1982): Oxidative biotransformation of drugs. In Arias I, Popper H, Schachter D, Shafritz DA (eds): "The Liver: Biology and Pathobiology." New York: Raven Press, pp 265-280.
2. Arand M, Grant DF, Beetham JK, Friedberg T, Oesch F, Hammock BD (1994): Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins - implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis. FEBS Lett 338:251-256.
3. Arand M, Mühlbauer R, Hengstler J, Jäger E, Fuchs J, Winkler L, Oesch F (1996): A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 236:184-186.
4. Artelt P, Morelle C, Ausmeier M, Fitzek M, Hauser H (1988): Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 68:213-219.
5. Barale R (1990): The genetic toxicology of styrene and styrene oxide. Mutat Res 257:107-126.
6. Bastlová T, Vodicka P, Peterková K, Hemminki K, Lambert B (1995): Styrene oxide-induced HPRT mutations. DNA adducts and DNA strand breaks in cultured human lymphocytes. Carcinogenesis 16:2357-2362.
7. Bialer M (1991): Clinical pharmacology of valpromide. Clin Pharmacokinet 20:114-122.
8. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 72:248-254.
9. Brown CD, Wong BA, Fennell TR (1996): In vivo and in vitro kinetics of ethylene oxide metabolism in rats and mice. Toxicol Appl Pharmacol 136:8-19.
10. Chen CL, Liu Q, Relling MV (1996a): Simultaneous characterization of glutathione S-transfersase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6:187-191.
11. Chen HW, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA (1996b): Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297.
12. Crespi CL, Langenbach R, Penman BW (1993): Human cell lines, derived from AHH-1 TK+/-human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology 82:89-104.
13. Davies RL, Crespi CL, Rudo K, Turner TR, Langenbach R (1989): Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagens. Carcinogenesis 10:885-891.
14. Dellarco VL, Generoso WM, Sega GA, Fowle JR III, Jacobson-Kram D (1990): Review of the mutagenicity of ethylene oxide. Environ Mol Mutagen 16:85-103.
15. 1. Proc Natl Acad Sci USA 85:5769-5773.
16. Dogra S, Doehmer J, Glatt HR, Moelders H, Siegert P, Friedberg T, Seidel A, Oesch F (1990): Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing. Mol Pharmacol 37:608-613.
17. Dypbukt JM, Costa LG, Manzo L, Orrenius S, Nicotera P (1992): Cytotoxic and genotoxic effects of styrene-7,8-oxide in neuroadrenergic Pc 12 cells. Carcinogenesis 13:417-424.
18. Eugster HP, Sengstag C, Hinnen A, Meyer UA, Wuergler FE (1991): Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae - Study of the valpromide carbamazepine epoxide interaction. Biochem Pharmacol 42: 1367-1372.
19. Filser JG, Bolt MM (1983): Exhalation of ethylene oxide by rats on exposure to ethylene. Mutat Res 120:57-60.
20. Föst U, Hallier E, Ottenwälder H, Bolt HM, Peter H (1991): Distribution of ethylene oxide in human blood and its implications for biomonitoring. Hum Exp Toxicol 10:25-31.
21. Friedberg T, Becker R, Oesch F, Glatt H (1994): Studies on the importance of microsomal epoxide hydrolase in the detoxification of arene oxides using the heterologous expression of the enzyme in mammalian cells. Carcinogenesis 15:171-175.
22. Fuchs J, Wullenweber U, Hengstler JG, Bienfait HG, Hiltl G, Oesch F (1994): Genotoxic risk for humans due to work place exposure to ethylene oxide: Remarkable individual differences in susceptibility. Arch Toxicol 68:343-348.
23. Glatt HR, Gemperlein I, Turchi G, Heinritz H, Doehmer J, Oesch F (1987): Search for cell culture systems with diverse xenobiotic-metabolising activities and their use in toxicological studies. Mol Toxicol 1:313-334.
24. Griffin MJ, Noda K (1980): Quantitation of epoxide hydrolase released from hyperplastic nodule and hepatoma microsomes. Cancer Res 40:2768-2773.
25. Hallier E, Langhof T, Dannappel D, Leutbecher M, Schröder K, Goergens HW, Müller A, Bolt HM (1993): Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: Influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 67:173-178.
26. Hammock BD, Loury DN, Moody DE, Ruebner B, Baselt R, Milam KM, Volberding P, Ketterman A, Talcott R (1984): A methodology for the analysis of the preneoplastic antigen. Carcinogenesis 5:1467-1473.
27. Hengstler JG, Fuchs J, Oesch F (1992): DNA strand breaks and DNA cross-links in peripheral mononuclear blood cells of ovarian cancer patients during chemotherapy with cyclophosphamide/carboplatin. Cancer Res 52:5622-5626.
28. Hengstler JG, Fuchs J, Gebhard S, Oesch F (1994): Glycolaldehyde causes DNA-protein crosslinks: A new aspect of ethylene oxide genotoxicity. Mutat Res 304:229-234.
29. Hengstler JG, Fuchs J, Tanner B, Oesch-Bartlomowicz B, Hölz C, Oesch F (1997): Analysis of DNA single-strand breaks in human venous blood: A technique which does not require isolation of white blood cells. Environ Mol Mutagen 29:58-62.
30. Herrero Plana ME (1995) Desarrollo y caracterización de sistemas celulares hepáticos con capacidad de biotransformación para estudios de hepatotoxicidad de xenobióticos, Thesis, Bioquímica y Biología Molecular. Universidad de Valencia, Valencia, Spain.
31. IARC (1994): IARC Monographs on the Evaluation of Carcinogenic Risks to Humans - Some Industrial Chemicals. Lyon: IARC.
32. Keown WA, Campbell CR, Kucherlapati RS (1990): Methods for introducing DNA into mammalian cells. In Goeddel DV (ed): "Methods in Enzymology: Gene Expression Technology." San Diego: Academic Press, pp 527-596.
33. Kohn KW (1991): Principles and practice of DNA filter elution. Pharmacol Ther 49:55-77.
34. Kohn KW, Ewig RAG, Erickson LC, Zwelling LA (1981): Measurement of strand breaks and cross-links by alkaline elution. In Friedberg EC, Hanawals PC (eds): "DNA Repair. A Laboratory Manual of Research Procedures." New York: Dekker, pp 379-401.
35. Kondo S, Carr BI, Takagi K, Huang TH, Chou YM, Yokoyama K, Itakura K (1990): Expression of rat microsomal epoxide hydrolase gene during liver chemical carcinogenesis. Cancer Res 50:6222-6228.
36. La Luna S, Soria I, Pulido D, Ortin J, Jimenez A (1988): Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene 62:121-126.
37. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
38. Lawley PD, Brookes P (1963): Further studies on the alkylation of nucleic acids and their constituent nucleotides. Biochem J 89:127-138.
39. Levin W, Lu AYH, Thomas PE, Ryan D, Kizer DE, Griffin MJ (1978): Identification of epoxide hydrase as the preneoplastic antigen in rat liver hyperplastic nodules. Proc Natl Acad Sci USA 75:3240-3243.
40. Lynch DW, Lewis TR, Moorman WJ, Burg JR, Groth DH, Khan A, Ackerman LJ, Cockrell BY (1984): Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F334 rats. Toxicol Appl Pharmacol 76:69-84.
41. Major J, Jakab MG, Tompa A (1996): Genotoxical investigation of hospital nurses occupationally exposed to ethylene-oxide. I. Chromosome aberrations, sister chromatid exchanges, cell cycle kinetics, and UV-induced DNA synthesis in pheripheral blood lymphocytes. Environ Mol Mutagen 27:84-92.
42. Mannervik B, Danielson VH (1988): Glutathione S-transferases. Structure and catalytic activity. CRC Crit Rev Biochem 23:283-337.
43. Martis L, Kroes R, Darby TD, Woods EF (1982): Disposition kinetics of ethylene oxide, ethylene glycol and 2-chloroethanol in the dog. J Toxicol Environ Health 10:847-856.
44. Nelson SD, Pearson PG (1990): Covalent and non-covalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol 30:169-195.
45. Norppa H, Hemminki K, Sorsa M, Vainio H (1981): Effect of monosubstituted epoxides on chromosome aberrations and SCE in cultured human lymphocytes. Mutat Res 91:243-250.
46. Oesch F (1973): Mammalian epoxide hydrases: Inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3:305-340.
47. Oesch F (1974): Purification and specificity of a human microsomal epoxide hydrolase. Biochem J 139:77-88.
48. Oesch F (1988): Antimutagenesis by shift in monooxygenase isoenzymes and induction of microsomal epoxide hydrolase. Mutat Res 202:335-342.
49. Oesch F, Jerina DM, Daly J (1971): A radiometric assay for hepatic epoxide hydrase activity with 7-3H-styrene oxide. Biochim Biophys Acta 227:685-691.
50. Oesch F, Vogel-Bindel U, Guenthner TM, Cameron R, Farber E (1983): Characterization of microsomal epoxide hydrolase in hyperplastic nodules. Cancer Res 43:313-319.
51. Oesch F, Hengstler JG, Arand M, Fuchs J (1995): Detection of primary DNA damage: Applicability to biomonitoring of genotoxic occupational exposure and in clinical therapy. Pharmacogenetics 5:S118-S122.
52. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994): Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276.
53. Pisani F, Fazio A, Oteri G, Spina E, Perucca E, Bertilsson L (1988): Effect of valpromide on the pharmacokinetiks of carbamazepine-10-11-epoxide. Br J Clin Pharmacol 25:611-613.
54. Prakash AS, Gibson NW (1992): Sequence-selective depurination, DNA interstrand cross-linking and DNA strand break formation associated with alkylated DNA. Carcinogenesis 13:425-431.
55. Robbins DK, Wedlund PJ, Elsberg S, Oesch F, Thomas H (1992): Interaction of valproic acid and some analogues with microsomal epoxide hydrolase. Biochem Pharmacol 43:775-783.
56. Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
57. Schmalix WA, Maser H, Kiefer F, Reen R, Wiebel FJ, Gonzalez F, Seidel A, Glatt H, Greim H, Doehmer J (1993): Stable expression of human cytochrome P450 1A1 cDNA in V79 Chinese hamster cells and metabolic activation of benzo(a)pyrene. Eur J Pharmacol Environ Toxicol 248:251-261.
58. Seidegård J, Pero RW, Miller DG, Beattie EJ (1986): A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7:751-753.
59. Singer B (1985): In vivo formation and persistence of modified nucleotides resulting from alkylating agents. Environ Health Perspect 62:41-48.
60. Skoda RC, Demierre A, McBride OW, Gonzalez FJ, Meyer UA (1988): Human microsomal xenobiotic epoxide hydrolase. J Biol Chem 263:549-1554.
61. Sumner SJ, Fennell TR (1994): Review of the metabolic fate of styrene. Crit Rev Toxicol 24:S11-S33.
62. Timms C, Schladt L, Robertson L, Rauch P, Schramm H, Oesch F (1987): The regulation of rat liver epoxide hydrolases in relation to that of other drug-metabolizing enzymes. In Benford DJ, Bridges JW, Gibson GG (eds): "Drug Metabolism from Molecules to Man." London: Taylor & Francis, pp 55-69.
63. Towbin H, Staehelin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
64. Vodicka P, Bastlová T, Vodicková L, Peterková K, Lambert B, Hemminki K (1995): Biomarkers of styrene exposure in lamination workers: Levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine-guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis 16:1463-1481.
65. Waxman JD, Lapenson DP, Morrissey JJ, Park SS, Gelboin HV, Doehmer J, Oesch F (1989): Androgen hydroxylation catalyzed by a cell line (SD1) that stably expresses rat hepatic P-450 PB-4 (IIB1). Biochem J 260:81-85.